BCC Research analyzes how innovation in biomanufacturing, ESG trends, and strategic investments are shaping the next frontier of protein-based therapeutics.”Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- ...
See how Concept Life Sciences accelerated early clinical trials by quickly transferring a client’s process and completing GMP manufacturing of CLS7001.
The Fmoc-Asp-OFm market is ripe with opportunities due to the rise of peptide-based therapeutics, automated synthesis technologies, and sustainable practices. Key opportunities include personalized ...
Privately held drug industry contract manufacturer PolyPeptide Group named a new chief executive on Tuesday ahead of a likely initial public offering (IPO) in Switzerland later this year.
Fujitsu Ltd, Mizuho Financial Group Inc, and drugmaker PeptiDream Inc said on Thursday they are forming a joint venture to develop treatments for COVID-19.